Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR7953ApriorityCriticalpatent/CR7953A/en
Publication of CR7953ApublicationCriticalpatent/CR7953A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto azabicilico sustituido de aminometilpiridiloximetilo/ bencisoxazol, una composicion farmaceutica que comprende el mismo y un metodo para tratar uno o mas trastornos del CNS u otros, que incluye el tratamiento concurrente de trastornos como esquizofrenia y depresion.A substituted azabicylic compound of aminomethylpyridyloxymethyl / bencisoxazole, a pharmaceutical composition comprising the same and a method for treating one or more CNS or other disorders, which includes the concurrent treatment of disorders such as schizophrenia and depression.
CR7953A2005-08-192005-08-19
BENCISOXAZETH PIRIDYLOXIMETHYL DERIVATIVES OF BENCISOXAZOL
CR7953A
(en)
COMPOUNDS DERIVED FROM IMIDAZOTRIAZINAS; PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF CANCER, ARTEROSCLEROSIS AND CARDIOVASCULAR DISEASES BETWEEN OTHERS.
COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ALLERGIC DISORDERS, AUTOIMMUNES, INFLAMMATORY DISEASES.
COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
6-oxo-1,6-dihydropyridazines; its uses to treat a hyperproliferative disorder; the pharmaceutical composition that contains them; and its preparation processes (div. sol. 1168-06).
Compounds derived from n- (1-4- (1h-pyrazol-5-yl) phthalazine-1-yl) piperidine-4-yl) benzamide; pharmaceutical composition that contains them, useful as antagonist of the hedgehog trajectory, in the treatment of cancer.
COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
Compounds derived from 3-benzoisoxazole-piperidine; pharmaceutical composition comprising said compounds; and its use for the treatment and / or prevention of cognitive disorders, drug addiction, depression, anxiety, among others.
Method for treating or preventing cancer, which comprises administering a synergistic pharmaceutical combination of: a) (s) -n- (3,4-difluoro-2- (2-fluoro-4-iodophenylamino) -6-methoxyphenyl) -1 - (2,3-dihydroxypropyl) cyclopropan-1-sulfonamide and b) 3- (6,7-bis (2-methoxyethoxy) quinazolin-4-ylamino) benzonitrile; pharmaceutical composition; and pharmaceutical kit.